VIM and cancer: Statistical analysis on Vimentin values with pN category and stages of the cancer patients showed that Vimentin has significantly (P value˂0.001) increased in cancer specimens with metastasis in 1 to 3 regional lymph nodes (pN1) relative to specimens with no regional lymph node metastasis (pN0) and also average of Vimentin in cancers with four or more metastasis regional lymph nodes was significantly (P value˂0.001) higher than all (Figure 4A(Fig. 4)).